{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:47:55Z","timestamp":1791920875658,"version":"4.3.4"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>A major complication of a joint replacement is prosthesis loosening caused by inflammatory osteolysis, leading to the revision of the operation. This is due to the abnormal activation of osteoclast differentiation and function caused by periprosthetic infection. Therefore, targeting abnormally activated osteoclasts is still effective for treating osteolytic inflammatory diseases. CDZ173 is a selective PI3K inhibitor widely used in autoimmune-related diseases and inflammatory diseases and is currently under clinical development. However, the role and mechanism of CDZ173 in osteoclast-related bone metabolism remain unclear. The possibility for treating aseptic prosthesis loosening brought on by inflammatory osteolysis illness can be assessed using an LPS-induced mouse cranial calcium osteolysis model. In this study, we report for the first time that CDZ173 has a protective effect on LPS-induced osteolysis. The data show that this protective effect is due to CDZ173 inhibiting the activation of osteoclasts <jats:italic>in vivo<\/jats:italic>. Meanwhile, our result demonstrated that CDZ173 had a significant inhibitory effect on RANKL-induced osteoclasts. Furthermore, using the hydroxyapatite resorption pit assay and podosol actin belt staining, respectively, the inhibitory impact of CDZ173 on bone resorption and osteoclast fusion of pre-OC was determined. In addition, staining with alkaline phosphatase (ALP) and alizarin red (AR) revealed that CDZ173 had no effect on osteoblast development <jats:italic>in vitro<\/jats:italic>. Lastly, CDZ173 inhibited the differentiation and function of osteoclasts by weakening the signal axis of PI3K-AKT\/MAPK-NFATc1 in osteoclasts. In conclusion, our results highlight the potential pharmacological role of CDZ173 in preventing osteoclast-mediated inflammatory osteolysis and its potential clinical application.<\/jats:p>","DOI":"10.3389\/fphar.2022.1021714","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T23:21:10Z","timestamp":1673047270000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Phosphatidyl Inositol 3-Kinase (PI3K)-Inhibitor CDZ173 protects against LPS-induced osteolysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Zuoxing","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12515","DOI":"10.1096\/fj.201802805RR","article-title":"Activation of ROS\/MAPKs\/NF-\u03baB\/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis","volume":"33","author":"An","year":"2019","journal-title":"FASEB J. official Publ. Fed. Am. Soc. Exp. Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1177\/0022034513500306","article-title":"Advances in the regulation of osteoclasts and osteoclast functions","volume":"92","author":"Boyce","year":"2013","journal-title":"J. Dent. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"110060","DOI":"10.1016\/j.cellsig.2021.110060","article-title":"YTHDF2 mediates LPS-induced osteoclastogenesis and inflammatory response via the NF-\u03baB and MAPK signaling pathways","volume":"85","author":"Fang","year":"2021","journal-title":"Cell. Signal."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3830212","DOI":"10.1155\/2020\/3830212","article-title":"Molecular and cellular pathways contributing to joint damage in rheumatoid arthritis","volume":"2020","author":"Fang","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"B5","doi-asserted-by":"publisher","first-page":"110353","DOI":"10.1016\/j.cellsig.2022.110353","article-title":"IL-10 inhibits osteoclast differentiation and osteolysis through MEG3\/IRF8 pathway","volume":"95","author":"Gao","year":"2022","journal-title":"Cell. Signal."},{"key":"B6","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41419-020-03046-z","article-title":"PERK controls bone homeostasis through the regulation of osteoclast differentiation and function","volume":"11","author":"Guo","year":"2020","journal-title":"Cell Death Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"110305","DOI":"10.1016\/j.biopha.2020.110305","article-title":"GSH attenuates RANKL-induced osteoclast formation in vitro and LPS-induced bone loss in vivo","volume":"128","author":"Han","year":"2020","journal-title":"Biomed. Pharmacother. = Biomedecine Pharmacother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e24780","DOI":"10.1371\/journal.pone.0024780","article-title":"Erk1 positively regulates osteoclast differentiation and bone resorptive activity","volume":"6","author":"He","year":"2011","journal-title":"PloS one"},{"key":"B9","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1021\/acsmedchemlett.7b00293","article-title":"Discovery of CDZ173 (leniolisib), representing a structurally novel class of PI3K delta-selective inhibitors","volume":"8","author":"Hoegenauer","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"B10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00774-020-01157-3","article-title":"Mechanisms of RANKL delivery to the osteoclast precursor cell surface","volume":"39","author":"Honma","year":"2021","journal-title":"J. Bone Min. Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s12016-019-08738-9","article-title":"Clinical, immunological, and genetic features in patients with activated PI3K\u03b4 syndrome (APDS): A systematic review","volume":"59","author":"Jamee","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"16014","DOI":"10.1038\/boneres.2016.14","article-title":"A review of UHMWPE wear-induced osteolysis: The role for early detection of the immune response","volume":"4","author":"Kandahari","year":"2016","journal-title":"Bone Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"482","DOI":"10.5483\/BMBRep.2021.54.9.070","article-title":"IRF2 enhances RANKL-induced osteoclast differentiation via regulating NF-\u03baB\/NFATc1 signaling","volume":"54","author":"Kim","year":"2021","journal-title":"BMB Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"E2073","DOI":"10.3390\/cells9092073","article-title":"Osteoblast-osteoclast communication and bone homeostasis","volume":"9","author":"Kim","year":"2020","journal-title":"Cells"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e10350","DOI":"10.1002\/jbm4.10350","article-title":"Increased osteoclast and decreased osteoblast activity causes reduced bone mineral density and quality in genetic hypercalciuric stone-forming rats","volume":"4","author":"Krieger","year":"2020","journal-title":"JBMR plus"},{"key":"B16","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1248\/bpb.b18-00026","article-title":"Anti-mouse RANKL antibodies inhibit alveolar bone destruction in periodontitis model mice","volume":"41","author":"Kuritani","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"B17","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41419-020-02947-3","article-title":"PKC-\u03b4 deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast-osteoblast uncoupling","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.12122\/j.issn.1673-4254.2020.10.09","article-title":"Zoledronate regulates osteoclast differentiation and bone resorption in high glucose through p38 MAPK pathway","volume":"40","author":"Lin","year":"2020","journal-title":"Nan fang yi ke da xue xue bao = J. South. Med. Univ."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.3390\/ijms23052868","article-title":"Piperlongumine inhibits titanium particles-induced osteolysis, osteoclast formation, and RANKL-induced signaling pathways","volume":"23","author":"Liu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"141638","DOI":"10.1016\/j.scitotenv.2020.141638","article-title":"Cadmium exposure triggers osteoporosis in duck via P2X7\/PI3K\/AKT-mediated osteoblast and osteoclast differentiation","volume":"750","author":"Ma","year":"2021","journal-title":"Sci. Total Environ."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1172\/JCI93356","article-title":"Inflammatory osteolysis: A conspiracy against bone","volume":"127","author":"Mbalaviele","year":"2017","journal-title":"J. Clin. Invest."},{"key":"B22","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.tem.2013.02.001","article-title":"Adenosine and bone metabolism","volume":"24","author":"Mediero","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jot.2022.04.001","article-title":"ZnO nanoparticles attenuate polymer-wear-particle induced inflammatory osteolysis by regulating the MEK-ERK-COX-2 axis","volume":"34","author":"Meng","year":"2022","journal-title":"J. Orthop. Transl."},{"key":"B24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11914-009-0004-5","article-title":"Denosumab: anti-RANKL antibody","volume":"7","author":"Miller","year":"2009","journal-title":"Curr. Osteoporos. Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jot.2022.01.003","article-title":"Puerarin specifically disrupts osteoclast activation via blocking integrin-\u03b23 Pyk2\/Src\/Cbl signaling pathway","volume":"33","author":"Qiu","year":"2022","journal-title":"J. Orthop. Transl."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1182\/blood-2017-08-801191","article-title":"Effective \u201cactivated PI3K\u03b4 syndrome\u201d-targeted therapy with the PI3K\u03b4 inhibitor leniolisib","volume":"130","author":"Rao","year":"2017","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11999-010-1645-5","article-title":"Continuous infusion of UHMWPE particles induces increased bone macrophages and osteolysis","volume":"469","author":"Ren","year":"2011","journal-title":"Clin. Orthop. Relat. Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1177\/10454411910020030601","article-title":"Osteoclast differentiation","volume":"2","author":"Roodman","year":"1991","journal-title":"Crit. Rev. Oral Biol. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"E1919","DOI":"10.3390\/ijms20081919","article-title":"The endocannabinoid\/endovanilloid system in bone: From osteoporosis to osteosarcoma","volume":"20","author":"Rossi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/jfb.14244","article-title":"Molecular characterization and expression analysis of two crucial MAPKs- jnk1 and erk1 as cellular signal transducers in Labeo rohita in response to PAMPs stimulation and pathogenic invasion","volume":"96","author":"Sadangi","year":"2020","journal-title":"J. Fish. Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"12701","DOI":"10.1002\/jcp.27887","article-title":"Diosmetin inhibits osteoclast formation and differentiation and prevents LPS-induced osteolysis in mice","volume":"234","author":"Shao","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00774-020-01191-1","article-title":"RANKL as the master regulator of osteoclast differentiation","volume":"39","author":"Takayanagi","year":"2021","journal-title":"J. Bone Min. Metab."},{"key":"B33","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.mce.2016.09.026","article-title":"Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice","volume":"439","author":"Tan","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00774-020-01162-6","article-title":"Osteoclast differentiation by RANKL and OPG signaling pathways","volume":"39","author":"Udagawa","year":"2021","journal-title":"J. Bone Min. Metab."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3389\/fphar.2019.01188","article-title":"Phillyrin attenuates osteoclast formation and function and prevents LPS-induced osteolysis in mice","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"17812","DOI":"10.1002\/jcp.28408","article-title":"Daphnetin attenuates LPS-induced osteolysis and RANKL mediated osteoclastogenesis through suppression of ERK and NFATc1 pathways","volume":"234","author":"Wu","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00223-020-00666-7","article-title":"New function of RUNX2 in regulating osteoclast differentiation via the AKT\/NFATc1\/CTSK Axis","volume":"106","author":"Xin","year":"2020","journal-title":"Calcif. Tissue Int."},{"key":"B38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/0022034510379019","article-title":"LPS promotes pre-osteoclast activity by up-regulating CXCR4 via TLR-4","volume":"90","author":"Xing","year":"2011","journal-title":"J. Dent. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s10020-018-0013-x","article-title":"Metformin suppresses UHMWPE particle-induced osteolysis in the mouse calvaria by promoting polarization of macrophages to an anti-inflammatory phenotype","volume":"24","author":"Yan","year":"2018","journal-title":"Mol. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"15395","DOI":"10.1074\/jbc.RA119.010139","article-title":"STAT3 controls osteoclast differentiation and bone homeostasis by regulating NFATc1 transcription","volume":"294","author":"Yang","year":"2019","journal-title":"J. Biol. Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"140214","DOI":"10.1172\/JCI140214","article-title":"Bone marrow adipogenic lineage precursors promote osteoclastogenesis in bone remodeling and pathologic bone loss","volume":"131","author":"Yu","year":"2021","journal-title":"J. Clin. Invest."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3389\/fphar.2019.01587","article-title":"Vindoline inhibits RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss in mice","volume":"10","author":"Zhan","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1002\/jcp.29205","article-title":"Antiosteoclastic bone resorption activity of osteoprotegerin via enhanced AKT\/mTOR\/ULK1-mediated autophagic pathway","volume":"235","author":"Zhao","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"27087","DOI":"10.3390\/ijms161125998","article-title":"Berberine sulfate attenuates osteoclast differentiation through RANKL induced NF-\u03baB and NFAT pathways","volume":"16","author":"Zhou","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"111857","DOI":"10.1016\/j.yexcr.2020.111857","article-title":"PP121 suppresses RANKL-Induced osteoclast formation in vitro and LPS-Induced bone resorption in vivo","volume":"388","author":"Zhou","year":"2020","journal-title":"Exp. Cell Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"5707242","DOI":"10.1155\/2021\/5707242","article-title":"Curculigoside protects against titanium particle-induced osteolysis through the enhancement of osteoblast differentiation and reduction of osteoclast formation","volume":"2021","author":"Zhu","year":"2021","journal-title":"J. Immunol. Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/jbmr.2710","article-title":"Alexidine dihydrochloride attenuates osteoclast formation and bone resorption and protects against LPS-induced osteolysis","volume":"31","author":"Zhu","year":"2016","journal-title":"J. Bone Min. Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1021714\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T23:21:28Z","timestamp":1673047288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1021714\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":47,"alternative-id":["10.3389\/fphar.2022.1021714"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1021714","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,6]]},"article-number":"1021714"}}